Ripple Biosolutions
Chris Raymond is a seasoned scientist and co-founder at Ripple Biosolutions, where efforts focus on pioneering advanced methods for early disease detection, particularly cancer. With a diverse background in both leadership and research roles, Chris served as Chief Scientific Officer at Salish Bioscience Inc. and Resolution Bioscience, where innovative capabilities for profiling solid tumor genomes through blood-based assays were developed. Earlier career experiences include senior research fellow positions at NuGEN Technologies and Merck, concentrating on product development and innovative assay development. Chris holds a PhD in Chemistry from the University of Oregon and a BS in Chemistry from the University of California, Santa Cruz.
This person is not in the org chart
This person is not in any teams
Ripple Biosolutions
We firmly believe in the promise of next-generation DNA sequencing (NGS) as an effective and ubiquitous clinical tool for molecular surveillance of a person’s health. Ripple Biosolutions supplies purified cell-free DNA (cfDNA) to use as both a research tool and as assay standards to promote this important work. Each lot of IsoPure cfDNA is produced from a single healthy human donor. This is an assay-ready, highly robust product that meets or exceeds performance of cfDNA purified by the current “gold standard” method. Please refer to the "Products" page on our website for further details.